Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: Aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia

Annals of Hematology

Volumn 77, Issue 6, 1998, Pages 261-264

  Elghetany, M T ^a   Vyas, S ^a   Yuoh, G ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Aplastic anemia; Bone marrow; Myelodysplastic syndrome; p53; Refractory anemia

Indexed keywords

ANTIBODY; PROTEIN P53; REAGENT;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW BIOPSY; BONE MARROW DEPRESSION; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; REFRACTORY ANEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; ANEMIA, REFRACTORY; ANTILYMPHOCYTE SERUM; BIOPSY; BONE MARROW; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; STAINING AND LABELING; T-LYMPHOCYTES;

EID: 0032406577     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050455     Document Type: Article

References (31)

1. Adamson DJA, Dawson AA, Bennett B, King DJ, Haites NE (1995) p53 mutation in the myelodysplastic syndromes. Br J Haematol 89:61-66
2. Aul C, Bowen DT, Yoshida Y (1998) Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. Haematologica (Pavia) 83:71-86
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199
4. Bogdanovi13æ AD, Trpinac DP, Jankovi13æ GM, Bumbasirevi13æ VZ, Obradovi13æ M, Colovi13æ MD (1997) Incidence and role of apoptosis in myelodysplastic syndrome: morphologic and ultrastructural assessment. Leukemia 11:656-659
5. waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma. Mod Pathol 10:1120-1127
6. Callera F, Falcao RP (1997) Increased apoptotic cells in bone marrow biopsies from patients with aplastic anemia. Br J Haematol 98:18-20
7. Cripps KJ, Purdie CA, Carder PJ, White S, Komine K, Bird CC, Wyllie AH (1994) A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene 9:2739-2743
8. Dix B, Robbins P, Carrello S, House A, Iacopetta B (1994) Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 70:585-590
9. Elghetany MT, Hudnall SD, Gardner FH (1997) Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis. Haematologica (Pavia) 82:21-24
10. Elghetany MT, Peterson B, MacCallum J, Nelson DA, Varney JF, Sullivan AK, Silverman LR, Schiffer CA, Davey FR, Bloomfield CD (1997) Deficiency of neutrophilic granule membrane glycoproteins in the myelodysplastic syndromes: a common deficiency in 216 patients studied by the Cancer and Leukemia Group B. Leuk Res 21:801-806
11. Elghetany MT, Vyas S, Youh G, Alter BP (1997) Pattern of p53 expression in bone marrow biopsies from patients with bone marrow failure: Fanconi's anemia, hypocellular refractory anemia and acquired aplastic anemia. Blood 90 [Suppl]: 12b
12. Elghetany MT, Peterson B, MacCallum J, Nelson DA, Varney JF, Sullivan AK, Silverman LR, Schiffer CA, Davey FR, Bloomfield CD (1998) Double esterase staining and other neutrophilic granule abnormalities in 237 patients with the myelodysplastic syndrome studied by the Cancer and Leukemia Group B. Acta Haematol 100:13-16
13. Felix CA, Hosler MR, Provisor D, Salhany K, Sexsmith EA, Slater DJ, Cheung N-K, Winick NJ, Strauss EA, Heyn R, Lange BJ, Malkin D (1996) The p53 gene in pediatric therapy-related leukemia and myelodysplasia. Blood 87:4376-4381
14. Fohlmeister I, Fischer R, Mödder B, Rister M, Schaefer H-E (1985) Aplastic anemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features. J Clin Pathol 38:1218-1224
15. Kaneko H, Misawa S, Horiike S, Nakai H, Kashim,a K (1995) TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities. Blood 85:2189-2193
16. Kitagawa M, Kamiyama R, Kasuga T (1993) Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia. Hum Pathol 24:359-363
17. Kitagawa M, Yoshida S, Kuwata T, Tanizawa T, Kamiyama R (1994) p53 expression in myeloid cells of myelodysplastic syndrome: association with evolution of overt leukemia. Am J Pathol 145:338-344
18. Lai J-L, Preudhomme C, Zandeck M, Flactif M, Vanrumbeke M, Lepelley P, Wattel E, Fenaux P (1995) Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of p53 mutations. Leukemia 9:370-381
19. Lepelley P, Preudhomme C, Vanrumbeke M, Quesnel B, Cosson A, Fenaux P (1994) Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia 8:1342-1349
20. Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351:453-456
21. Maschek H, Kaloutsi V, Rodriguez-Kaiser M, Werner M, Chortiz H, Mainzer K, Dietzfelbinger M, Georgii A (1993) Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis. Ann Hematol 66:117-122
22. Nand S, Godwin JE (1988) Hypoplastic myelodysplastic syndrome. Cancer 62:958-964
23. Ohara A, Kojima S, Hamajima M, Tsuchida M, Imashuku S, Ohta S, Sasaki H, Okamura J, Sugita K, Kigasawa H, Kiriyama Y, Akatsuka J, Tsukimoto I (1997) Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood 90:1009-1013
24. Orazi A, Cattoretti G, Heerema NA, Sozzi G, John K, Neiman RS (1993) Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies. Mod Pathol 6:521-525
25. Orazi A, Kahasi M, John K, Neiman RS (1996) p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis. Mod Pathol 9:48-52
26. Orazi A, Albitar M, Heerema NA, Haskins S, Neiman RS (1997) Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am J Clin Pathol 107:268-274
27. Raza A, Gezer S, Mundle S, Gao X-Z, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A, Loew J, Marcus B, Khan Z, Chaney C, Showel J, Gregory S, Preisler H (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86:268-276
28. Saad STO, Vassallo J, Arruda VA, Lorand-Metze I (1994) The role of bone marrow study in diagnosis and prognosis of myelodysplastic syndrome. Pathologica 86:47-51
29. Tenaud C, Negoescu A, Labat-Moleur F, Legros Y, Soussi T, Brambilla E (1994) p53 immunolabeling in archival paraffin-embedded tissues: optimal protocol based on microwave heating for eight antibodies on lung carcinomas. Mod Pathol 7:853-859
30. Tsushita K, Hotta T, Ichikawa A, Saito H (1992) Mutation of p53 gene does not play a critical role in myelodysplastic syndrome and its transformation to acute leukemia. Br J Haematol 81:456-457
31. Tuzuner N, Cox C, Rowe JM, Watrous D, Bennett JM (1995) Hypocellular myelodysplastic syndromes: new proposals. Br J Haematol 91:612-617